Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 28, 2013

Primary Completion Date

September 5, 2017

Study Completion Date

September 28, 2017

Conditions

Disorder of Glucose Regulation

Interventions

DRUG

Sitagliptin-Metformin

Experimental -dipeptidyl peptidase-4 (DPP-4) inhibitor- oral medication

DRUG

Metformin

Biguanide- insulin sensitizer

DRUG

Placebo pill

Will evaluate effect of lifestyle and diet only

Trial Locations (1)

Woman's Hospital, Baton Rouge

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Woman's

OTHER

NCT01856907 - Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM | Biotech Hunter | Biotech Hunter